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The diseases that prevailed in the 60s and 70s have not completely disappeared, 
tuberculosis is still endemic and some transmissible diseases may reoccur while 
some others, such as cancers, cardiovascular and metabolic disorders are dramati-
cally increasing, requiring the implementation of effective health care programs.
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Objectives: Colorectal cancer is the third most frequently diagnosed cancer in 
the United States adult population with a projected mortality of more than 50,000 
people in 2013. The purpose of this study was to examine patient, physician, and 
access-to-care factors that may influence the utilization of timely screening for 
colorectal cancer among US adults aged 50 years and above. MethOds: The data 
source for this study was the 2009-2011 Medical Expenditure Panel Survey (MEPS). A 
multivariate binary logistic regression was used to examine the association between 
the predictor variables (patient demographics, physician attributes, and access-to-
care characteristics) and the outcome variable (colorectal screening) for individuals 
in group I (50-75 years of age) as well as in group II (> 75 years of age). Data were 
analyzed using SAS version 9.3. Results: A total of 11,370 respondents, 50 years 
and above, were eligible for colorectal cancer screening as stated by the guidelines. 
Of these, 65% (n= 7393) were adherent to recommended colorectal cancer screening 
guidelines. For group I, the regression analysis showed that the odds of undergoing 
colorectal cancer screening are significantly higher with increasing age, education, 
and family income, living in an urban area, and availability of health insurance and 
self-transportation to health services locations. Similarly for group II, the regression 
analysis revealed that the odds of colorectal cancer screening were higher with 
increasing family income and availability of self-transportation. Conversely, the 
odds of screening were lower in individuals with good to excellent health status 
for groups I and II. cOnclusiOns: Developing policies and programs to educate 
and promote awareness in rural areas, low-income groups, among those with better 
health conditions, and in those seeking primary care treatment could improve the 
colorectal cancer screening rate.
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Objectives: To examine factors associated with chronic obstructive pulmonary 
disease (COPD)-related inpatient readmission among managed care patients in the 
US. MethOds: This retrospective administrative claims database analysis included 
patients with COPD (≥ 1 inpatient or emergency room claim or ≥ 2 outpatient claims 
with a diagnosis of COPD [ICD-9-CM codes 491.xx, 492.xx, 494.xx, or 496.xx]), aged 
≥ 40 years with health plan enrollment in 2011. From this cohort, patients with a 
COPD-related hospitalization (hospitalization with a primary diagnosis of COPD) 
and continuous enrollment for ≥ 30 (30-day cohort) or ≥ 90 (90-day cohort) days 
post-discharge were selected for further analysis. Percentages of patients with a 
COPD-related inpatient readmission in the 30 and 90 day periods post-discharge 
were reported. Logistic regression models assessed clinical (i.e., length of stay [LOS] 
for the initial hospitalization; COPD-related medications received [e.g. long-acting 
bronchodilators (LABDs)] and COPD-related pulmonologist visits post-initial hos-
pitalization; and comorbidity burden, being newly diagnosed with COPD, and COPD 
complexity pre-hospitalization) and demographic factors associated with 30- and 
90-day readmission. Results: 49,986 and 38,241 patients had a COPD-related hos-
pitalization in 2011 with ≥ 30 and ≥ 90 days of continuous enrollment following 
discharge, respectively (representing 5.4% and 4.1% of COPD patients). Readmission 
within 30 and 90 days was observed in 7.1% and 13.5% of patients, respectively. In 
both cohorts, the strongest predictor of readmission was high complexity COPD 
(versus low complexity) (odds ratio [OR]= 2.8 and 2.2, both P< 0.0001), followed by 
LOS for the initial hospitalization > 10 days (versus 1-3 days, OR= 2.6 and 2.0, both 
P< 0.0001), and Charlson Comorbidity Index (CCI) score ≥ 3 (versus CCI= 0) (OR= 2.2, 
P< 0.0001 for both cohorts). Receipt of a LABD was associated with decreased odds of 
readmission in the 90-day cohort (OR= 0.88, P= 0.0009). cOnclusiOns: More com-
plex COPD, greater comorbidity burden, and longer LOS for the initial hospitalization 
each contribute to an increased risk of COPD-related readmission.
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Objectives: Cycling has always been a very popular means of transportation and 
a leisure activity recently. However, bicycle-related injuries should be given recogni-
tion as a significant issue because of the annual mortality rate increased and heavy 
cost due to cycling injuries. The purposes of this study were to describe the bicycle-
related injury hospitalization, and to examine the association between health care 
utilization and patients’ characteristics in Taiwan. MethOds: This secondary data 
analysis was a retrospective cross sectional study. Data came from the hospitaliza-
tion claims in National Health Insurance data set between 2007 and 2011. Study 
samples were identified as those hospitalizations with ICD9-CM external cause of 
injury codes related to bicycle-related injuries. We hypothesized that the number of 
hospitalization, the length of stays (LOS), and medical expenditures vary by patients’ 
gender, age, injury type, and collision with vehicles. We took log transformation of 
LOS and expenditures to adjust for the skewed nature before analyzing multiple 
linear regression. Results: The admissions because of bicycle-related injuries 
increased since 2007, and the average admission was 6,882 per year. In terms of 
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Objectives: To assess the impact of the drug price submitted by pharmaceutical 
manufacturers and the impact of the level of therapeutic improvement as deter-
mined by the Patented Medicine Price Review Board (PMPRB) for a sample of drugs 
evaluated by the pan Canadian Pricing Alliance (pCPA), on the time-to-listing of 
these drugs on provincial drug plan formularies across Canada. MethOds: Drugs 
evaluated by pCPA were grouped according to their daily cost versus their compara-
tors and their level of therapeutic improvement. Analyses were conducted to deter-
mine which of these factors had an impact on the national median time-to-listing 
as measured in days starting from the date of the Common Drug Review (CDR) or 
the pan-Canadian Oncology Drug Review (pCODR) final recommendation. The pro-
vincial median time-to-listing for products having received a CDR recommendation 
since 2010 were compared between products not evaluated by the pCPA and those 
evaluated by the pCPA. Results: For drugs evaluated by the pCPA, the national 
median time-to-listing differed among drugs offering a slight or no improvement in 
therapy, ranging from 190 days for products with prices lower than their compara-
tors, up to 345 days for medicines with prices higher than their comparators. For 
the latter group, the level of therapeutic improvement appeared to be an important 
factor to guarantee quicker access to new treatments. The national median time-
to-listing were shorter for products considered as substantial improvement (166 
days) compared to drugs offering a moderate improvement (325 days) and a slight 
or no improvement (345 days) in therapy. The implementation of the pCPA further 
affected the provincial median time-to-listing, increasing these by 26 days up to 
247 days depending on the jurisdictions. cOnclusiOns: The pCPA negotiations are 
influenced by drug prices and the level of therapeutic improvement of the drugs, 
and seemingly increase the time-to-listing of medicines on provincial drug plan 
formularies in Canada.
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Objectives: It was performed a diagnosis of the correlation among Multidimensional 
Poverty Index (MPI) (Colombian Adaptation) with quality of health services proxy vari-
ables, and inequality and poverty variables(2005). MethOds: An ecological study was 
performed: the MPI was adapted by the Colombian government using the Alkire Foster 
Method of the Oxford Poverty and Human Development Initiative. The Unsatisfied 
Basic Needs indicator (UBNI), Gini coefficient (GC) and poverty line (PL) were obtained 
from National Statistics Department´s (DANE) databases. Maternal Mortality Rate 
(MMR) and Neonatal Mortality Rate (NMR) were estimated and standardized by age 
and sex, respectively. We estimated the Incidence of congenital syphilis (ICS). The 
Attributable Fraction (AF) was calculated as inequality indicator for these three vari-
ables: (AFMMR), (AFNMR) and (AFICS). We estimated Acute Myocardial Infarction Age-
Standarized Rate (AMIASR) for each health regime. The Inequity in Health Index (IHI) 
was estimated. These data were estimated for each Colombian region for the year 
2005, because MPI was specified in the same way for the same period. Normality 
was tested using the Shapiro-Wilks test. Sperman’s rho and Pearson’s rho were 
used according to normality. It was defined as correlated if p≤ 0.005, after Bonferroni 
adjustment. Results: We found correlation between MPI and PL (Pearson r= -0.7748, 
p= 0.0000); and UBNI (Spearman rho= 0.8286, p= 0.0000); there was not correlation with 
GC (Pearson r= -0.1785, p= 0.4041); AFMMR (Spearman rho= 0.3553, p= 0.054); AFNMR 
(Spearman rho= 0.3386, p= 0.0539); AFICS (Spearman rho= –0.0543, p= 0.7757); AMIASR 
subsidized regime, (Spearman rho= 0.3032, p= 0.0917), AMIASR, contributory regime, 
(Pearson r= 0.31, p= 0.1084). IHI: Spearman rho= 0.3081, p= 0.0811). cOnclusiOns: 
We found correlation between MPI, PL and UBNI. There were not correlation with 
proxy variables in health, which suggests that MPI’s health dimension was not well 
adjusted for the Colombian case.
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Objectives: To draw up an inventory of health care systems in the North African 
region (Algeria, Morocco and Tunisia), highlighting the opportunities and the chal-
lenges of these countries, and to provide an overall view of the progresses made 
and the shortcomings that persist. MethOds: A descriptive comparative approach 
of health care systems in the three countries, based on data from Sherbrooke 
University (Canada), the World Health Organization and the IPEMEDreport issued 
in 2012. Results: The number of physicians per 1000 inhabitants: 1.43 in Tunisia, 
1.24 and 0.67 in Algeria and Morocco, respectively. Population is aging and life expec-
tancy exceeds 70 years at birth for men and women. Child mortality per 1000 live 
births is 16 in Tunisia, 30 and 33 in Morocco and Algeria, respectively. Health care 
yearly expenditure per capita is $ 275 in Tunisia, 245 in Algeria and 195 in Morocco. 
Public expenditure on health care as % of GDP (estimate) 3.64% in Algeria, 6,3% in 
Tunisia and 6,2 % in Morocco. Access to health care is a common problem for all 
three countries, even if in Tunisia, the offer is the most comprehensive. Rate of hos-
pital beds per 1000 inhabitants is 2.1 in Tunisia, 1.7 and 1.1 in Algeria and Morocco, 
respectively. Despite substantial progress, maternal mortality rate remains high 
in Algeria and Morocco: 120 and 110 per 100 000 births, respectively (60/100 000 in 
Tunisia). Cardiovascular disorders are the most common cause of death followed 
by cancers and metabolic diseases. cOnclusiOns: The transition that the North 
African countries are undergoing is a real challenge for health care authorities. 
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department anytime during 2010 and at least one readmission within 30 days were 
included. A multivariate marginal Cox model using clustering of admissions within 
patients was employed to test the association between DHR and LOS. Results: 
16,922 readmitted patients with a total of 27,057 readmissions comprised the study’s 
cohort. Of these, 2,015 (11.9%) had a DHR. Factors that were associated with DHRs: 
index hospital size (OR: 2.60 and 1.28 for small and medium hospitals, compared 
to large), younger age (age 18-44, OR= 1.7), being male (OR= 1.13) and long LOS (8+ 
days) in the index hospitalization (OR= 1.33). Residency in a nursing home and 
chronic conditions like COPD, Asthma, Disability and Alcohol were associated with 
a decreased likelihood of DHRs. The mean LOS in same-hospital readmissions was 
shorter by almost one day as compared with the mean LOS for DHRs, 6.1 (95% CI: 
6.0-6.2) vs. 6.9 (95% CI: 6.6-7.2), respectively. One of the strongest predictors of longer 
LOS was DHR (HR= 0.88 p< 0.001). cOnclusiOns: Adjusting to key confounders, 
when readmission is to a different-hospital than the index admission, there is 
increased average LOS. Such an outcome can signify breakdowns in continuity of 
care and a need to create more seamless care processes when patients are readmit-
ted to a different hospital.
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Objectives: In the fall of 2009, two Canadian provinces, BC and Alberta, allowed 
pharmacists to deliver immunizations (policy provinces), while other provinces 
across the country either did not change their legislation or implemented this pol-
icy after 2010 (non-policy provinces). The purpose of this study was to investigate 
the impact of pharmacist delivered immunizations on influenza immunization 
rates. We also evaluated perceptions of individuals around the need for immuni-
zation in those provinces that changed policy in 2009 compared to those that did 
not. MethOds: The Canadian Community Health Survey (CCHS) is a nationally 
representative survey that reports results every two years. With respect to influenza 
immunization, respondents were asked whether or not they received an immuniza-
tion in the past year and if not, they were asked if they believe immunization was 
unnecessary. Hierarchical logistic regression was employed, clustering respondents 
by province of residence, to examine trends in these two outcomes from 2007/08 
(prior to policy implementation) to 2009/10 (after policy implementation). Results: 
Between 2007/08 and 2009/10, the adjusted odds of getting an influenza immuniza-
tion decreased by 22% (p< 0.01) in non-policy provinces, but increased by 4% (p= 0.06) 
in policy-provinces. The adjusted odds of ‘thinking an immunization is unneces-
sary’ increased across Canada, but at a slower rate in provinces that received the 
policy. The odds of ‘thinking an immunization is unnecessary’ increased by 27% 
(p< 0.01) in non-policy provinces compared to a 6% (p< 0.05) increase in policy-prov-
inces. cOnclusiOns: Our findings suggest that the pharmacist immunization pol-
icy has not yet remarkably improved immunization rates, but may have prevented 
a more severe decline that was experienced by non-policy provinces. It may have 
contributed to a smaller increase in perception that immunization is unneces-
sary relative to non-policy provinces. Further research is needed to ensure that 
pharmacist delivered immunization improves population level immunization rates.
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Objectives: The prevalence of diabetes mellitus (DM) is about 11.3% among 
adult residents in Singapore. Diabetic retinopathy (DR) is the leading cause of 
blindness among diabetic patients. In Singapore, annual screening for DR using 
retinal photograph is suggested for all diagnosed DM patients regardless of their 
risks of developing DR. This study aimed to develop and validate a prognostic 
model to stratify diabetic patients into different risk groups. MethOds: A pre-
dictive model was developed using retrospective data. Diabetic patients who did 
screening in NHG polyclinics in year 2010-2011 were included. Variables included 
in the model were patient demographics (age, gender, ethnic group); comorbid 
conditions (hypertension, dyslipidemia; stroke, chronic kidney disease, peripheral 
cardiovascular disease, peripheral neuropathy); duration of diabetes; average & 
maximum Hba1c level in last 1 year; treatment agents; BMI and smoking status. 
Cox regression was used to ascertain the time to development of retinopathy. 
Stepwise algorithm with Bayesian information Criteria were applied for selecting 
the best fit model. Results: Six predictors significantly predicted the time to 
develop diabetic retinopathy. Predictors ranked by their relative importance were, 
average hba1c level in last 1 year, age, stroke, duration of diabetes, dyslipidemia, 
peripheral neuropathy. Harrell’s C concordance statistic was 0.66 (95%CI: 0.63-0.69), 
and the c-statistics of ROC for 1-year DR-free was 0.73 (95%CI: 0.72-0.75), which 
showed a good discrimination power of the model. Cox-Snell residual plot showed 
the predicted time to event fit the actual time. cOnclusiOns: A risk stratification 
model for predicting the time to develop DR among diabetic patients has been 
developed and validated to help physicians make decisions on the optimal time 
for DR screening given the patients risk profile.
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diagnoses of injury, fracture ranked the first (47.1%), followed by TBI (33.8%). 
Regarding the types of traffic accident, most of the hospitalizations (74.6%) 
were collisions with vehicles involving cars or motorcycles. Patients who aged 
more than 65 years old, and waived copayment had significantly longer LOS 
(p< 0.05). cOnclusiOns: We found that the hospitalizations distribution of bicycle-
related injuries differed from patients’ demographic characteristics. This finding 
can be used to promote bicycle safety on preventing injuries through different 
stakeholders such as health, or transportation, and local governments.
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Objectives: There has been an increase in employee wellness programs that 
include $0 co-pays for basic preventive medications. Although existing literature 
suggests $0 co-pays may increase adherence, there is uncertainty on how these 
programs impact total employee health care costs. This study examines the finan-
cial impact of $0 co-pays for a large integrated health care system. MethOds: The 
$0 co-pay program included approximately 200 anti-hypertensive, anti-diabetic, 
and anti-lipid medications for Geisinger Health System (GHS) employees starting 
in 2007. Data is from the Geisinger Health Plan (GHP) in Pennsylvania for the years 
2005-2011. The intervention group (GHS employees who received one or more of 
the $0 co-pay drugs during the study period) were propensity score matched based 
on 2 years of baseline data to the comparison group (non-GHS employees with 
GHP coverage who received the same drugs during the same time). A 2-part multi-
variate regression model was used to estimate the per member per month (PMPM) 
dollar effect. A separate multivariate regression model estimated the incremental 
changes in drug spending associated with the $0 co-pay to calculate the return on 
investment (ROI). Results: The sample included 2,251 GHS employees (interven-
tion group) and 3,857 non-GHS employees (comparison group). The outcome vari-
able was the total medical allowed amount (amount paid by the health plan plus 
the member out-of-pocket cost) excluding the Rx drug cost. The average medical 
allowed amount among the GHS employees was reduced by $99 PMPM during the 
study period. This translated to a 12% savings over the 5-year study period relative 
to the non-GHS employee group. Considering the foregone copay and the incre-
mental drug spending associated with the $0 co-pay, our results suggest an ROI of 
1.7. cOnclusiOns: Implementation of $0 co-pays can potentially lead to net cost 
savings. Future research needs to examine how programs might achieve cost savings 
by analyzing its impact on health.
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Objectives: The top 5% of health care users based on total expenditures [High 
Resource Patients (HRP)] account for roughly half of all health care costs. The dis-
tribution of health care expenditures for HRP is likely to differ from the overall 
population. By examining spending patterns of HRP, we can better understand the 
components of health care expenditures that drive overall spending. MethOds: 
We performed a retrospective analysis of managed care enrollees across the full 
age and care spectrum, by examining health care claims obtained from the IMS 
LifeLink Health Plan Claims (HPC) Database. A total of 15,587,257 health plan mem-
bers met our selection criteria, of which 779,364 were classified as HRP. We compared 
expenditures during CY2011 by place of service (Outpatient, Inpatient, Pharmacy) 
and payer type (Commercially insured, Medicare Advantage, and Medicaid man-
aged care) between the full population and HRP. Results: Inpatient hospitalization 
accounted for more direct health care expenditures for HRP (40.0%) than expendi-
tures from pharmacy services (18.1%) or from major outpatient places of service 
[Ambulatory Surgical Center (ASC) 20.3%, Physician Visits (PV) 4.9%, and Emergency 
Department (ED) 2.7%]. The share of overall expenditures attributed to inpatient 
services was higher for HRP compared to the full population (24.6%) while the share 
of expenditures attributed to pharmacy and outpatient services was reduced (Rx: 
21.4%, ASC: 19.7%, PV: 11.7%, ED: 4.5% in the full population). This pattern was 
observed across payer type. The use of physician-administered pharmaceuticals did 
not alter this spending pattern. cOnclusiOns: Policy efforts to address health care 
cost inflation can only succeed if they address HRP, who drive overall health care 
spending disproportionately. Understanding patterns of spending in this popula-
tion can help in devising cost reduction strategies. Policy makers should focus on 
integrated care for HRP, including appropriate use of pharmaceuticals, so as to 
potentially reduce costly downstream inpatient expenditures.
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Objectives: Recent studies show that about 20% of readmissions are to a different 
hospital than the index admission. In non-same hospital readmissions there exists 
a risk for fragmentation and loss of information. We aimed to test risk factors for 
different hospital readmissions (DHR) and whether DHRs are associated with worse 
outcomes, specifically longer length of stay (LOS) as compared with same hospital 
readmissions. MethOds: A retrospective cohort study of hospitalized members 
of Clalit Health Services, Israel’s largest non-for-profit health care organization. 
All Clalit members that had at least one hospitalization in an internal medicine 
